LOBO Vascular Occlusion System
Okami Medical, Inc. · Decision date Oct 6, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the LOBO Vascular Occlusion System, submitted by Okami Medical, Inc. of Aliso Viejo, California, under 510(k) number K262798. The decision date is 06 October 2026; the application was received 07 August 2026. The device falls under regulation 870.3300, classification name "Device, Vascular, For Promoting Embolization," product code KRD, with the Cardiovascular medical specialty and review panel. A SESE decision is a 510(k) clearance, not a premarket approval of the device.
The record identifies the submission as a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public page does not state which predicate device was used, what the substantial-equivalence basis was, or what indications, components or labeling the clearance covers; those details would sit in the underlying FDA documents rather than this summary page. No clinical or performance conclusions are drawn here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 6, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262798
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Okami Medical, Inc.
- Product code
- KRD
- Decision code
- SESE
- Decision date
- Oct 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Device, Vascular, For Promoting Embolization.
- Applicant
- Okami Medical, Inc.
- Product code
- KRD
- FDA device class
- 2
FDA decision timeline
K262798 received
Application receipt date recorded by FDA.
K262798 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Okami Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Aliso Viejo, CA
Sources and methodology
- Original FDA record: K262798
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records